NCT06396845View on ClinicalTrials.gov

Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

CompletedOBSERVATIONAL
Enrollment

505

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2022

Study Completion Date

January 3, 2024

Conditions
RoboticLaparoscopicAnterior Resection for Rectal Cancer
Interventions
PROCEDURE

robotic surgery

robotic surgery

PROCEDURE

laparoscopic surgery

laparoscopic surgery

Trial Locations (1)

225001

Northern Jiangsu People's Hospital, Yangzhou

All Listed Sponsors
lead

Daorong Wang

OTHER

NCT06396845 - Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI) | Biotech Hunter | Biotech Hunter